GlycoMimetics Inc [GLYC] Records 200-Day SMA of $1.98

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. GlycoMimetics Inc shares valued at $41,956 were purchased by Rock Edwin on Sep 22 ’23. At $1.38 per share, Rock Edwin acquired 30,403 shares. The insider’s holdings grew to 375,403 shares […]

Understanding the Risks of Investing in GlycoMimetics Inc (GLYC)

GlycoMimetics Inc’s filing revealed that its Chief Medical Officer Rock Edwin acquired Company’s shares for reported $41956.0 on Sep 22 ’23. In the deal valued at $1.38 per share,30,403 shares were bought. As a result of this transaction, Rock Edwin now holds 375,403 shares worth roughly $0.98 million. Then, Rock Edwin bought 35,000 shares, generating […]

GlycoMimetics Inc [GLYC] Investment Appeal on the Rise

GlycoMimetics Inc’s filing revealed that its Chief Medical Officer Rock Edwin acquired Company’s shares for reported $41956.0 on Sep 22. In the deal valued at $1.38 per share,30,403 shares were bought. As a result of this transaction, Rock Edwin now holds 375,403 shares worth roughly $1.21 million. Then, Rock Edwin bought 35,000 shares, generating $48,300 […]

GlycoMimetics Inc [GLYC] Investment Guide: What You Need to Know

GlycoMimetics Inc’s recent filing unveils that its Chief Medical Officer Rock Edwin acquired Company’s shares for reported $41956.0 on Sep 22. In the deal valued at $1.38 per share,30,403 shares were bought. As a result of this transaction, Rock Edwin now holds 375,403 shares worth roughly $1.16 million. Then, Rock Edwin bought 35,000 shares, generating […]